BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+17.96%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$407M
AUM Growth
+$407M
(-11%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-30.69%
Top 10 Holdings %
Top 10 Hldgs %
60.98%
Holding
46
New
5
Increased
6
Reduced
20
Closed
12
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$19.2M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$18.8M |
| 3 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$15.5M |
| 4 |
SIEN
Sientra, Inc.
SIEN
|
$8.62M |
| 5 |
Heron Therapeutics
HRTX
|
$8.37M |
Top Sells
| 1 |
Iovance Biotherapeutics
IOVA
|
$67.9M |
| 2 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$12.6M |
| 3 |
Aclaris Therapeutics
ACRS
|
$12.2M |
| 4 |
Catalyst Pharmaceutical
CPRX
|
$11.9M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$10.9M |
Sector Composition
| 1 | Healthcare | 88.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $38.2M | 8.32% | 1,559,299 -2,769,004 | -64% | -$67.9M |
|
|
PETX
2
DELISTED
Aratana Therapeutics, Inc.
PETX
| $37.5M | 8.15% | 7,258,135 | – | – |
|
|
NVRO
3
DELISTED
NEVRO CORP.
NVRO
| $31.7M | 6.89% | 488,265 -134,350 | -22% | -$8.71M |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $29.6M | 6.45% | 676,879 +429,979 | +174% | +$18.8M |
|
5
Travere Therapeutics
TVTX
$1.56B
| $21.2M | 4.6% | 1,053,314 +37,200 | +4% | +$747K |
|
|
BDSI
6
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $19.9M | 4.33% | 4,281,943 -93,123 | -2% | -$433K |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $19.2M | 4.18% | +114,804 | New | +$19.2M |
|
|
EIGR
8
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $17.6M | 3.82% | 1,656,137 +1,462,837 | +757% | +$15.5M |
|
|
GBT
9
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $16.7M | 3.62% | 316,619 -78,690 | -20% | -$4.14M |
|
|
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
| $16.5M | 3.58% | 344,762 -26,936 | -7% | -$1.29M |
|
|
SCTL
11
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $15.9M | 3.46% | 1,561,617 -348,378 | -18% | -$3.54M |
|
|
12
Heron Therapeutics
HRTX
$207M
| $12.2M | 2.66% | 657,998 +450,000 | +216% | +$8.37M |
|
|
13
Catalyst Pharmaceutical
CPRX
$2.52B
| $10.6M | 2.31% | 2,765,070 -3,091,928 | -53% | -$11.9M |
|
14
DexCom
DXCM
$29.5B
| $9.49M | 2.06% | 63,300 -4,200 | -6% | -$629K |
|
|
AVDL
15
Avadel Pharmaceuticals
AVDL
$1.43B
| $8.97M | 1.95% | 3,102,673 | – | – |
|
|
SIEN
16
DELISTED
Sientra, Inc.
SIEN
| $8.62M | 1.88% | +1,400,000 | New | +$8.62M |
|
|
LJPC
17
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $8.25M | 1.79% | 891,760 -1,103,151 | -55% | -$10.2M |
|
18
Strata Skin Sciences
SSKN
$9.93M
| $8.11M | 1.76% | 3,256,615 +390,292 | +14% | +$972K |
|
|
SBBP
19
DELISTED
Strongbridge Biopharma plc.
SBBP
| $7.97M | 1.73% | 2,544,839 -247,210 | -9% | -$774K |
|
|
VRAY
20
DELISTED
ViewRay, Inc.
VRAY
| $7.63M | 1.66% | 866,500 | – | – |
|
21
Sol-Gel Technologies
SLGL
$63.5M
| $6.65M | 1.45% | 730,100 -117,600 | -14% | -$1.07M |
|
22
SI-BONE Inc
SIBN
$719M
| $6.36M | 1.38% | +312,898 | New | +$6.36M |
|
|
QTNT
23
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $5.98M | 1.3% | 639,756 -458,900 | -42% | -$4.29M |
|
|
ATRS
24
DELISTED
Antares Pharma, Inc.
ATRS
| $5.74M | 1.25% | 1,744,147 -899,800 | -34% | -$2.96M |
|
25
Incyte
INCY
$16.5B
| $5.66M | 1.23% | 66,600 -33,400 | -33% | -$2.84M |
|